A Cohort Study of Thiazolidinediones and Fractures in Older Adults with Diabetes

AUTOR(ES)
FONTE

The Endocrine Society

RESUMO

Context: Thiazolidenediones (TZDs) are selective ligands of peroxisome-proliferator-activated receptor-γ and have been shown to reduce bone mineral density. Recent results from several randomized controlled trials find an increased risk of fracture with TZDs compared with other oral antidiabetic agents.

Documentos Relacionados